Page 8 - Pfizer
As many remain unvaccinated, debate grows over need for booster Covid shots
Experts say to prevent the coronavirus from morphing into even more dangerous forms than the Delta variant, the more urgent need is to protect the unvaccinated.
 "As many remain unvaccinated, debate grows over need for booster Covid shots")
Pfizer says booster shots of vaccine restore waning immunity
No new unexpected side effects were identified from safety data associated with boosters in the final-stage study
 "Pfizer says booster shots of vaccine restore waning immunity")
Gennova's mRNA vaccine to come in powder form; will stay stable at 2-8 °C
The lyophilized vaccine will come in a powder form and it will be mixed with diluents before administration
 "Gennova's mRNA vaccine to come in powder form; will stay stable at 2-8 °C")
UK approves Pfizer, AstraZeneca vaccines as booster doses for Covid-19
The UK's health regulator has approved Pfizer and AstraZeneca vaccines for booster doses against Covid-19, even as the country's decision on the third dose remains pending.
 "UK approves Pfizer, AstraZeneca vaccines as booster doses for Covid-19")
80% Covid immunity lost in 6 months in some after Pfizer shot: US study
The researchers particularly looked at humoral immunity - also called antibody-mediated immunity - to measure the body's defences
 "80% Covid immunity lost in 6 months in some after Pfizer shot: US study")
Pfizer booster likely by September 20, Moderna may be delayed: Fauci
Maryland Governor Larry Hogan, a Republican, criticised the Biden administration for "mixed messaging."
EU regulator evaluating if Covid-19 vaccine booster dose is needed
The European Medicines Agency says it has started an expedited evaluation on whether to recommend a booster dose of the coronavirus vaccine made by Pfizer-BioNTech
 "EU regulator evaluating if Covid-19 vaccine booster dose is needed")
Pfizer to offer small Covid vax packaging to cut wastage of doses
US drug maker Pfizer aims to roll out smaller packages of its Covid-19 vaccine for public health departments and care providers by October, media reports said.
Pfizer Covid booster shot likely to start by Sep 20 in US, says Fauci
The US' booster shot campaign against Covid-19 will likely start with only the Pfizer vaccine from September 20, the country's top infectious disease expert has said
One Covid-19 vaccine makes more antibodies than another. Does it matter?
Now, subtle differences between the Pfizer Inc.-BioNTech SE and Moderna Inc. vaccines are emerging across patient groups over time.
 "One Covid-19 vaccine makes more antibodies than another. Does it matter?")
Taiwan gets first Pfizer-BioNTech vaccines against Covid after long delay
Taiwan received its first batch of Pfizer-BioNTech vaccines Thursday after a prolonged purchasing process that gave rise to a political blame game with China
Covid vaccines may become a viable business, but that's not good news
Vaccines are not consumer products made by pharmaceutical industry: they are infrastructure.
New Zealand reports first death linked to Pfizer Covid-19 vaccine
An independent Covid-19 vaccine safety monitoring board considered that the woman's death was due to myocarditis, which is known to be a rare side effect of the Pfizer Covid-19 vaccine
'Pfizer jab side effects in 12-15 year olds at high risk, mild to moderate'
A new study has revealed that the side effects of the Pfizer-BioNTech jab against COVID-19 in 12-15-year-olds at high risk of complications from the infection are likely to be mild to moderate
 "'Pfizer jab side effects in 12-15 year olds at high risk, mild to moderate'")
US plans Covid-19 booster shots at six months instead of eight: Report
Pfizer and BioNTech have already started the application process for the approval of its booster shot in people 16 and older
Heart inflammation more common after Covid than Pfizer vaccine: Study
Pfizer's Covid vaccine has been linked with an increased risk of developing myocarditis -- a type of heart inflammation.
Pfizer seeking FDA approval for coronavirus vaccine booster dose
Pfizer is seeking US approval of a booster dose of its two-shot COVID-19 vaccine. The drugmaker said Wednesday that it has started the application process for a third dose of its vaccine for people ages 16 and older. The company said it will complete the application with the Food and Drug Administration by the end of this week. The company's move follows an announcement by U.S. health officials last week of plans to give COVID-19 booster shots to all Americans to shore up their protection amid the surging delta variant of the virus. Officials said it is very clear that the vaccines' protection against COVID-19 infections wanes over time. Pfizer's vaccine received full FDA approval earlier this week; it had been used since last December under an emergency use authorization. The three vaccines used in the U.S. made by Pfizer, Moderna and Johnson & Johnson are still preventing hospitalizations and deaths from COVID-19. But the vaccines don't appear quite as strong against the highly .
Explained: What FDA full approval to Pfizer-BioNTech vaccine means
The research to develop a safe and effective Covid-19 vaccine was accelerated in 2020
Fauci expects uptick in vaccine administration after FDA OKs Pfizer shot
Dr. Anthony Fauci says he's hoping for an uptick in the administration of Covid-19 vaccinations following US government approval of the Pfizer vaccine
 "Fauci expects uptick in vaccine administration after FDA OKs Pfizer shot")
US FDA grants full approval to Pfizer-BioNTech Covid vaccine
The FDA approved the two-dose vaccine for use in people over the age of 16.
 "US FDA grants full approval to Pfizer-BioNTech Covid vaccine")
